HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John M Timmerman Selected Research

Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)

3/2009Carrier protein conjugate vaccines: the "missing link" to improved antibody and CTL responses?
1/2009Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells.
1/2009Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma.
9/2008Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas.
6/2003Immunotherapy for lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John M Timmerman Research Topics

Disease

33Neoplasms (Cancer)
01/2022 - 02/2002
24Lymphoma (Lymphomas)
01/2019 - 02/2002
22B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 02/2002
9Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2017 - 02/2002
7Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2019 - 02/2002
5Disease Progression
01/2020 - 03/2002
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 11/2013
4Neutropenia
01/2019 - 10/2009
3Body Weight (Weight, Body)
01/2020 - 01/2015
3Multiple Myeloma
01/2019 - 01/2016
3Leukemia
01/2019 - 01/2016
3Hodgkin Disease (Hodgkin's Disease)
10/2018 - 01/2015
2Residual Neoplasm
06/2022 - 03/2002
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2022 - 01/2020
2Fatigue
09/2016 - 10/2009
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2012 - 09/2008
2Melanoma (Melanoma, Malignant)
10/2009 - 09/2008
1Lymphatic Metastasis
01/2022
1Cytokine Release Syndrome
01/2021
1Thrombocytopenia 3
01/2019
1Exanthema (Rash)
09/2016
1Hematologic Neoplasms (Hematological Malignancy)
01/2016
1Drug-Related Side Effects and Adverse Reactions
01/2015
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2012
1Breast Neoplasms (Breast Cancer)
06/2012
1Anorexia
10/2009
1Ovarian Neoplasms (Ovarian Cancer)
10/2009
1Thrombocytopenia (Thrombopenia)
10/2009
1Diarrhea
10/2009
1Abdominal Pain (Pain, Abdominal)
10/2009
1Headache (Headaches)
10/2009

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2002
14VaccinesIBA
03/2009 - 03/2002
11Rituximab (Mabthera)FDA Link
01/2022 - 06/2003
7Monoclonal AntibodiesIBA
01/2019 - 06/2003
7AntibodiesIBA
10/2012 - 03/2002
5Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA
03/2009 - 06/2003
5Neoplasm Antigens (Tumor Antigens)IBA
01/2009 - 08/2002
4Chimeric Antigen ReceptorsIBA
06/2022 - 12/2017
4CytokinesIBA
01/2022 - 06/2003
4NivolumabIBA
01/2019 - 01/2015
4LigandsIBA
10/2018 - 02/2002
4interleukin-21 (interleukin 21)IBA
01/2017 - 09/2008
4Immunoglobulins (Immunoglobulin)IBA
06/2014 - 03/2002
4Carrier Proteins (Binding Protein)IBA
03/2009 - 09/2008
4keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
03/2009 - 09/2008
3axicabtagene ciloleucelIBA
01/2021 - 12/2017
3Lipase (Acid Lipase)FDA Link
01/2019 - 09/2016
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2017 - 09/2012
3Glutaral (Glutaraldehyde)IBA
03/2009 - 09/2008
3maleimideIBA
01/2009 - 09/2008
2brexucabtagene autoleucelIBA
06/2022 - 01/2020
2Pharmaceutical PreparationsIBA
10/2018 - 09/2016
2Interferon-alpha (Interferon Alfa)IBA
01/2018 - 04/2010
2AntigensIBA
12/2017 - 03/2009
2Immunoglobulin FragmentsIBA
12/2017 - 09/2009
2Interferon Type IIBA
10/2016 - 06/2013
2Complement System Proteins (Complement)IBA
09/2012 - 07/2009
2OligodeoxyribonucleotidesIBA
09/2012 - 07/2009
2Immunoglobulin G (IgG)IBA
09/2008 - 10/2002
2DNA (Deoxyribonucleic Acid)IBA
06/2003 - 10/2002
1Zirconium-89IBA
01/2022
1Therapeutic UsesIBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1tocilizumab (atlizumab)FDA Link
01/2021
1Antigen Receptors (Antigen Receptor)IBA
01/2021
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2020
1AnthracyclinesIBA
01/2019
1Antisense OligonucleotidesIBA
01/2019
1diphenyleneiodoniumIBA
01/2019
1Metformin (Glucophage)FDA LinkGeneric
01/2019
1PerhexilineIBA
01/2019
1HexokinaseIBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
01/2019
1Protein Isoforms (Isoforms)IBA
01/2018
1fludarabineIBA
12/2017
1Radioisotopes (Radionuclides)IBA
12/2017
1obinutuzumabIBA
12/2017
1Bortezomib (Velcade)FDA Link
10/2016
1Brentuximab VedotinIBA
09/2016
1Antigen-Antibody Complex (Immune Complex)IBA
02/2015
1Janus KinasesIBA
01/2015
1Interleukin-12 (IL 12)IBA
10/2014
1InterleukinsIBA
10/2014
1InterferonsIBA
10/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2014
1Vincristine (Oncovin)FDA LinkGeneric
06/2014
1Prednisone (Sone)FDA LinkGeneric
06/2014
1pidilizumabIBA
11/2013
1Trastuzumab (Herceptin)FDA Link
06/2012
1B7-H1 AntigenIBA
07/2011
1Indicators and Reagents (Reagents)IBA
04/2010
1IpilimumabIBA
10/2009

Therapy/Procedure

16Therapeutics
01/2020 - 08/2002
9Immunotherapy
01/2018 - 02/2003
7Drug Therapy (Chemotherapy)
01/2020 - 03/2002
3Stem Cell Transplantation
01/2019 - 01/2015
1Autologous Transplantation
01/2019
1Cell Transplantation
10/2018
1Hematopoietic Stem Cell Transplantation
11/2013